Twist Bioscience Corporation (BIT:1TWST)
22.96
0.00 (0.00%)
At close: Nov 18, 2025
Twist Bioscience Revenue
In the fiscal year ending September 30, 2025, Twist Bioscience had annual revenue of $376.57M USD with 20.32% growth. Twist Bioscience had revenue of $99.01M in the quarter ending September 30, 2025, with 16.88% growth.
Revenue
$376.57M
Revenue Growth
+20.32%
P/S Ratio
4.73
Revenue / Employee
$384.65K
Employees
979
Market Cap
1.52B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 376.57M | 63.60M | 20.32% |
| Sep 30, 2024 | 312.97M | 67.87M | 27.69% |
| Sep 30, 2023 | 245.11M | 41.54M | 20.41% |
| Sep 30, 2022 | 203.57M | 71.23M | 53.83% |
| Sep 30, 2021 | 132.33M | 42.23M | 46.87% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Stellantis | 146.12B |
| Eni S.p.A. | 86.56B |
| Enel SpA | 77.78B |
| Assicurazioni Generali | 56.79B |
| Intesa Sanpaolo | 25.32B |
| UniCredit | 24.85B |
| Prysmian | 19.49B |
| Leonardo S.p.a. | 19.13B |